TRADING UPDATES: Equipmake hails "key milestone" for Project Coeus
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 62.50p on 08-10-2026 at 09:45:41 |
|---|---|
| Change | -1.00p -1.57% |
| Buy | 63.00p |
| Sell | 62.00p |
| Last Trade: | Buy 100,000.00 at 62.50p |
| Day's Volume: | 2,086,954 |
| Last Close: | 63.50p |
| Open: | 63.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 62.25p - 64.80p |
| 52wk Range: | 49.00p - 90.50p |
| Market Capitalisation: | £273.52m |
| VWAP: | 63.68504p |
| Shares in Issue: | 437.63m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 100,000 | 62.50p | Ordinary |
10:45:26 - 08-Oct-26 |
| Buy* | 100,000 | 62.50p | Ordinary |
10:45:23 - 08-Oct-26 |
| Buy* | 10,000 | 62.50p | Ordinary |
10:43:10 - 08-Oct-26 |
| Buy* | 2,480 | 62.50p | Ordinary |
10:41:01 - 08-Oct-26 |
| Buy* | 17,609 | 62.50p | Ordinary |
10:39:02 - 08-Oct-26 |
| Buy* | 9,592 | 62.50p | Ordinary |
10:38:48 - 08-Oct-26 |
| Buy* | 148 | 62.50p | Ordinary |
10:38:39 - 08-Oct-26 |
| Buy* | 3 | 62.50p | Ordinary |
10:38:24 - 08-Oct-26 |
| Buy* | 694 | 62.50p | SI Trade |
10:37:43 - 08-Oct-26 |
| Sell* | 195,613 | 62.00p | Ordinary |
10:37:39 - 08-Oct-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 6th Oct 2026 7:00 am | RNS | Results of Placing and Subscription |
| 5th Oct 2026 4:22 pm | RNS | Proposed Fundraise to raise approximately £12.5m |
| 30th Sep 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 30th Sep 2026 7:01 am | RNS | Capital Access Window |
| 30th Sep 2026 7:00 am | RNS | Interim Results for Six Months to June 30, 2026 |
| 25th Sep 2026 8:00 am | RNS-R | pre|CISION® Platform Wins R&D Achievement Award |
| 25th Sep 2026 7:00 am | RNS | Further Demonstration of Potential of AVA6103 |
| 16th Sep 2026 7:00 am | RNS | Clinical Proof of Mechanism for preCISION Platform |
| 14th Sep 2026 7:00 am | RNS | Mats Blom to Board as Chair of Audit Committee |